Omega-3 is known to enhance the effects of several chemotherapeutic agents and to exert several immunoregulatory actions In the present study, we evaluated the effects of a 21-day feeding regimen with omega-3-rich fish oil (FO) and its corresponding control, omega-6 rich corn oil (CO), on the BU-CY conditioning and the development of GVHD after BMT in mice. Before conditioning, FO, but not CO, feeding caused a significant attenuation in the number and functionality of splenic FoxP3 þ T regulatory cells (Treg). FO feeding also enhanced the effects of the conditioning through severe depletion of Treg cells in the spleen and CD11b þ myeloid cells in both the BM and spleen. Consequently, FO-fed animals conditioned with BU-CY showed exacerbated GVHD following transplantation with allogeneic BM and splenic cells. In contrast, identical transplantation in CO-fed mice resulted in poor engraftment and body weight loss. Moreover, in standard-fed recipients, BMT with cells from FO-fed donors resulted in moderate GVHD and improved the survival time, whereas BMT with cells from CO-fed donors shortened the survival time and caused anemia. We conclude that food supplements should be considered in patients undergoing BMT and/or chemotherapy treatment.
INTRODUCTION
Omega-3 fatty acids (FAs), which are abundant in fatty fish, sea foods and organ meats belong to a group of essential polyunsaturated FA that have a key role in human health and disease conditions. 1, 2 Consumption of diets containing omega-3 FA has been shown to reduce the risk for the development of cardiovascular diseases 2 and improve the pathophysiological processes in various diseases including atherosclerosis, diabetes, degenerative neurological disorders, pregnancy, cancer progression and immune-mediated diseases such as rheumatoid arthritis and inflammatory bowel disease. 2, 3 Although the exact mechanisms underlying the beneficial effects of omega-3 FA remain to be elucidated, incorporation of these compounds into the plasma membrane, modulation of intracellular signaling pathways and alteration of gene expression have been suggested to be involved 1, 4, [5] [6] [7] [8] Clinical, experimental and mechanistic studies have shown that dietary omega-3 exerts its potent immunomodulatory and antiinflammatory properties via various mechanisms, which involve decreasing the expression of costimulatory molecules, reduction of proliferative capacity of stimulated T cells, changing T-cell membrane structure, modification of intracellular signaling, inhibition of DC maturation, imbalance of T-cell subsets (for example, CD4 vs CD8; Th1 vs Th2), enhancing Ag-inducing cell death and suppression of cytokine production. 2, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] Furthermore, it has been demonstrated that dietary supplementation with omega-3 can affect the process of hematopoiesis in the BM by increasing the differentiation and at the same time reducing the frequency of myeloid progenitor cells. 9, 23 In addition to being a potent anti-inflammatory natural product, dietary omega-3 can also be used as complementary medicine in cancer therapy. 24 In fact, studies have shown that omega-3 can enhance the efficacy and/or facilitate the uptake of the chemotherapeutic drug, which results in a significant decrease in tumor size and prolongation of survival rate, without causing severe side effects. [25] [26] [27] Hematopoietic SCT (HSCT) is the treatment of choice for several hematological malignancies and solid tumors. 28 Unfortunately, the use of HSCT is limited by GVHD, the major complication of allogeneic HSCT. 29 Although a number of studies have addressed the effects of omega-3 supplementation on tumor growth, cytotoxic drug response and effects on the immune system, 9, 30, 31 there is insufficient knowledge of its effects on the process of HSCT and the development of GVHD. Thus, on the basis of available data regarding the effects of omega-3 in anticancer drug toxicity and immune function, we hypothesized that supplementation of diet with this natural compound would affect conditioning regimen, outcome and immune system recovery after HSCT. To test this hypothesis, we studied the effects of omega-3 fish oil (FO) and omega-6 corn oil (CO) dietary supplements on BU-CY conditioning regimen and allogeneic HSCT outcome, including occurrence and severity of GVHD in mice. were purchased from Scanbur (Sollentuna, Sweden) and kept under pathogen-free conditions in a 12-h light/dark cycle with humidity (55%±5%), temperature (21±2 1C) and high-efficiency particulate air-filtered air, and they had access to food and water ad libitum. Animals were allowed to acclimatize 1-2 weeks before each experiment. The study was approved by the Stockholm Southern animal research ethics committee and carried out in accordance with Swedish Animal Welfare legislation.
MATERIALS AND METHODS Animals

Dietary composition
All diets were prepared under sterile conditions. To obtain an FO-rich diet, R36 standard chow (Lantmännen, Kimstad, Sweden) was supplemented with 9% menhaden FO plus 1% CO to prevent essential FA deficiency. The CO-rich diet was prepared by adding 10% CO to R36 chow. Tert-butylhydroquinone (0.1%) and a-tocopherol (0.04%) (MP Bio-medicals, Ilkirch, France) were added to both diets to prevent oxidation. Standard R36 chow without additives was used as the control diet. Energy, carbohydrate, protein and fat contents, as well as FA composition and omega-6/omega-3 ratio prepared diets, are shown in Supplementary Information S1.
Experimental setting
As several studies have shown that short-term dietary exposure to FO can modulate immune functions in mice, 18, [32] [33] [34] we mainly used a 21-day exposure period in our study (see below). For comparison, we also used a 2-month exposure period. However, for practical reasons, animals in this later feeding setting were not used for BMT.
Three groups of female BALB/c mice (20 mice/group) were fed either a standard diet (standard-fed group) or diets containing FO or CO for a total of 21 consecutive days. On day 14, 15 mice from each group received a myeloablative BU-CY conditioning regimen as previously described. 35 Briefly, animals were administered BU (80 mg/kg) (Sigma-Aldrich, Stockholm, Sweden) for 4 days followed by CY (200 mg/kg) (SigmaAldrich, Stockholm, Sweden) for 2 days. Thereafter, the animals were rested for 1 day before BMT. On day 21 of dietary treatment, 5-6 mice from each conditioned group and their corresponding control groups were killed by cervical dislocation. The spleens and femur bones were dissected out for further analysis (see below). The remaining animals were transplanted with 20 Â 10 6 BM cells in combination with 30 Â 10 6 splenocytes obtained from allogeneic male C57BL/6 mice. Thereafter, all the transplanted animals were fed a standard diet and monitored for the development of GVHD as described previously. 35 For the 2-month exposure period, FO-, CO-and standard-fed groups were conditioned with BU-CY on day 49 and killed on day 56.
We also examined whether dietary exposure of donor mice to FO or CO can alter the outcome of GVHD in the recipient animals. Thus, in a separate experiment, three groups of donor male C57BL/6 mice (7 mice/group) were fed FO, CO or standard food for 3 weeks before harvesting the BM cells and splenocytes, whereas recipient female BALB/c mice were fed standard food. After BU-CY conditioning, recipient mice were divided into three groups. Groups I, II and III received BM and splenocytes from FO-, COand standard-fed donors. After transplantation, all groups were monitored for the development of GVHD as described previously. 35 Preparation of cell suspensions from the BM and spleen BM cells were flushed out of the femurs using sterile phosphate-buffered saline containing 2% fetal calf serum and 0.01 mM EDTA by means of a syringe connected to a 27-gauge needle and subsequently washed twice with phosphate-buffered saline. The spleens were cut into smaller pieces and gently passed through a 70-mm strainer (BD Falcon, BD, Franklin Lakes, NJ, USA) using a syringe plunger. BM and splenic cell suspensions were centrifuged, and the pellets were resuspended in 1 ml of ammonium chloride (Stem Cell Technologies, Vancouver, BC, Canada) to lyse the RBCs. BM cells and splenocytes were then washed twice with sterile phosphatebuffered saline before subsequent use. anti-CD25-PerCp-Cy5.5 (clone: PC61), anti-CD11b-PerCp-Cy5.5 (clone: M1/ 70); anti-CD4 labeled with ( À ) Allophycocyanin (APC) (clone: RM4-5), anti-CD19-APC (clone: 1D3), anti-CD62L-APC (clone: MEL-14) and anti-CD11c-APC (clone: HL3). All Abs were purchased from BD-Pharmingen (San Diego, CA, USA). For cell-surface staining, BM or splenocytes were incubated with the selected Abs in the dark, on ice, for 30 min. After washing, the cells were analyzed using FACSCalibur (BD Biosciences, San Jose, CA, USA).
Flow cytometric analysis
For splenic FoxP3 intracellular staining, splenic cells were stained with anti-CD4 and anti-CD25 Ab and then permeabilized and stained with antiFoxP3-PE Ab (eBiosciences, San Diego, CA, USA, clone: FJK-16s).
Assessment of regulatory T-cell function
Regulatory T-cell (Treg) function was assessed with MLC. Splenic Treg cells were purified by immunomagnetic bead isolation using a MACS Treg isolation kit according to the manufacturer's recommendations (Miltenyi Biotec, Fisher Scientific, Gö teborg, Sweden). Splenocytes from untreated female BALB/c mice were used as responder (Tresp) cells. The Tresp cells were stimulated with anti-mouse CD3e (BD biosciences, Stockholm, Sweden) at two different concentrations (3 mg/mL and 10 mg/mL). Different ratios of Tresp to Treg were used as follows: 1:1 (1 Â 10 
Statistical analysis
Statistical analysis and graph preparation were done using SPSS (IBM Corp. Armonk, NY, USA) and GraphPad Prism (GraphPad software, Inc, La Jolla, CA, USA). Student's t-test was used for two-group comparison. A value of Po0.05 was considered a significant finding.
RESULTS
Body weight changes
All fed groups gained weight during the 2-week feeding (Table 1) , and as expected BU-CY conditioning induced a significant body weight loss, which was more pronounced in both FO-and CO-fed mice than the standard-fed animals ( Table 1) .
Effects of a 21-day dietary supplementation with FO and CO on the spleen and BM cell populations before BU-CY conditioning The total number of splenocytes was not affected by a 21-day feeding with FO or CO (Figure 1a) . Without affecting other cell populations, FO feeding significantly attenuated the number of Treg (CD4 þ CD25 þ Foxp-3 þ ) cells, whereas CO feeding increased the number of these cells in the spleen (Figure 1b) . None of Figure 1a ), these cells were more attenuated in animals fed with FO and CO for 2 months (Figure 2d ). Analysis of cell phenotypes showed that splenic Treg and CD11b þ myeloid cells were more reduced in conditioned mice fed with FO for 21 days than those in their corresponding CO-and standard-fed mice (Figures 2b and c) .
Furthermore, these cells, as well as dendritic (CD11c þ CD86 þ ), naïve cytotoxic T (CD8 þ CD44 À CD62 þ ) and memory cytotoxic T (CD8 þ CD44 þ CD62 À ) cells, were more attenuated in conditioned animals fed with FO for 2 months than the corresponding standard-fed mice (Figures 2e-i) . In contrast, compared with these control animals, CO-fed mice exhibited more decreased splenic CD11b þ myeloid and memory cytotoxic T cells (Figures 2f and i ) The effect of omega-3 on BMT outcome S Al Hashmi et al
We also observed that BU-CY administration caused an enhanced reduction in the number of CD11b þ myeloid cells in the BM of mice fed with FO for 21 days or 2 months compared with those in CO-and standard-fed animals (Figures 3a and b ).
Dietary supplementation with FO suppresses the regulatory activity of Treg cells With regard to our above findings that FO feeding before and after BU-CY conditioning largely affected Treg cells, we next examined whether FO could also alter the function of these cells using a MLC assay. As shown in Figures 3a-c, a 21 -day dietary supplementation with FO, but not with CO, was associated with deteriorating suppressive properties of Treg cells. This difference was retained even with a low ratio of Treg to responder cells and was independent of anti-CD3 concentration (Figures 4a-c) .
Pre-feeding of recipient mice with FO exacerbates GVHD after allogeneic BMT The development of acute GVHD was monitored in allogeneic BMtransplanted BALB/c mice pre-fed with control diet or diets containing FO or CO for a total of 21 days. Following transplantation, FO-fed mice developed severe diarrhea as a typical sign of GVHD, and all died within 8 days (P ¼ 0.02) (Figure 5a ). Although transplanted CO-fed recipients also survived for a significantly shorter period than the corresponding standard-fed mice (general survival time: 14 vs 21 days; P ¼ 0.04, Figure 5a ), CO-fed animals were less prone to develop diarrhea and appeared to be more anemic.
Transplantation with BM and splenic cells from donors pre-fed with FO or CO differentially affects the outcome of GVHD in standard-fed recipient mice In a separate experiment, BM and splenic cells from C57BL/6 mice pre-fed with FO, CO or standard chow for 21 days were transplanted into standard-fed and BU-CY-conditioned BALB/c mice, and the development of GVHD was monitored. As shown in Figure 5b , the survival time in recipient mice receiving cells from FO-fed donors was relatively longer than those transplanted with cells from standard-fed mice (median survival time: 25 vs 16 days). Moreover, the clinical signs of GVHD (hair loss and diarrhea) were relatively similar in both groups. On the other hand, recipient mice transplanted with cells from CO-fed donor mice died within 2 weeks owing to weight loss without developing diarrhea or hair loss (Figure 5b ).
DISCUSSION
Although the potency of omega-3 FO has been evaluated for direct effects on tumor progression or anticancer drug toxicity in several experimental systems, its interactions with host anticancer immunity was less extensively investigated. 36 In the context of BMT, to our knowledge, no previous studies have systematically evaluated the effects of FO and CO on the outcome of BMT. To elucidate the effects of these compounds on the host immune system during conditioning chemotherapy and BMT, we used our previously established chemotherapy-based GVHD mouse model. 35 Several novel findings of potential clinical relevance emerged.
Our most important novel observation was that, compared with standard-and CO-fed recipient mice, recipient animals fed with FO lived for a shorter time and exhibited more pronounced signs of acute GVHD (acute onset of severe diarrhea) after allogeneic BMT. At the same time, CO-fed mice also exhibited a worse posttransplant prognosis (anemic appearance, subacute onset of weight decline), without exhibiting typical signs of GVHD. These findings suggest that FO and CO feeding differentially exacerbate the outcome of GVHD, that is in FO-fed recipients allogeneic BMT resulted in a successful engraftment and subsequent exacerbation The effect of omega-3 on BMT outcome S Al Hashmi et al of GVHD, whereas in CO-fed mice allogeneic BM transplants engrafted poorly and caused anemia and weight loss. Obviously, further studies are required to further support this suggestion. In this connection, it is also of great interest to investigate whether FO and/or CO dietary supplementation would also affect the outcome of BMT when the recipients are fed after BMT. We are now in the process of performing this investigation in our laboratory. Treg are known to have an important role in immunologic tolerance by decreasing the risk of autoimmunity and regulating an inflammatory situation, for example,. attenuation of acute GVHD. 37, 38 The expression of FoxP3 is considered a hallmark of these cells in mice. In this connection, our second important novel finding was that a number of splenic FoxP3 þ Treg cells were significantly attenuated in FO-fed mice both before and after BU-CY conditioning. Moreover, we found that dietary supplementation with FO also reduced the suppressive property of Treg in a functional in vitro assay. Thus, it is very likely that attenuation of FoxP3 þ Treg cells contribute to the rapid death of FO-fed mice by enhancing the severity of GVHD. In line with this likelihood, reduction of FoxP3 expression either in the graft 39, 40 or in the recipient 38 has been shown to be associated with increased acute GVHD severity.
Our third novel observation was that BMT from FO-fed donors was associated with moderate GVHD and improved survival time, whereas recipients transplanted with cells from CO-fed donors died within a short time and appeared severely anemic. This finding suggests that the outcome of BMT can also be altered differently by dietary supplementation of donors with FO or CO. The exact underlying mechanisms for these differential effects remain to be elucidated. However, on the basis of our finding that the number of splenic FoxP3 þ Treg cells was decreased by FO feeding, but increased by CO feeding, we suggest that administration of those BM preparations that contain a low number of these cells will result in a successful engraftment, whereas BM preparations containing a high number of FoxP3 þ Treg cells will engraft poorly. This suggestion is currently being tested in our laboratory.
Finally, we observed that FO, but not CO, dietary supplementation had the ability to enhance the effects of BU-CY conditioning by further reducing the number of CD11 þ myeloid cells in both the spleen and BM. Furthermore, a 2-month FO feeding was associated with a lower frequency of splenic dendritic and naïve cytotoxic T-cell populations. Indeed, these findings are consistent with the general idea that FO can increase the efficacy of chemotherapeutic drugs. 24 Collectively, our findings illuminate one more part of the complex interactions between dietary fats and immunity with special regard to anticancer treatment. In conclusion, we present novel data elucidating the effects of the common dietary omega-3 and omega-6 FA on immune function and complications following myeloablative chemotherapy and allogeneic BMT in a wellestablished mouse model. Although the clinical relevance of our findings remains to be investigated, our data suggest the need for a cautious attitude toward adding supra-physiological concentrations of polyunsaturated FA to enteral and parenteral nutritional supports in conjunction with high-dose chemotherapy and BMT. and transplanted using 1.0 Â 10 7 BM and 2.0 Â 10 7 splenic cells from male C57Bl/6 donors fed standard food. The survival curves of FOand CO-fed groups were both significantly lower compared with the standard food group (P ¼ 0.02 and P ¼ 0.04 ,respectively). (b) Female BALB/c mice in three groups conditioned with BU-CY (80 mg/kg-200 mg/kg). Each group was transplanted using 1.0 Â 10 7 BM and 2.0 Â 10 7 splenic cells from male C57Bl/6 donors that were fed FO (red solid line), CO (green dashed line) or standard diet for 3 weeks. All recipient mice were fed standard food before transplantation. Red solid line: donors were fed a diet containing FO for 21 days, and recipients were fed standard food before and after transplantation. Green dashed line: donors were fed a diet containing CO for 21 days, and recipients were fed standard food before and after transplantation. Blue dashed line: donors were fed standard chow for 21 days and recipients were fed standard chow before and after transplantation. Feeding of the donors with FO prolonged the survival of the transplanted mice in the group that continued with standard diet (median survival time: 25 vs 16 days in standard-fed donors).
